Investors Working in & Seeking Therapeutic Opportunities
Moderator: Ronjon Nag, PhD, Founder & Managing Director, R42 Group
Kan Chen, PhD, Principal, Qiming Venture Partners
Shaan Gandhi, MD, DPhil, Principal, Northpond Ventures
Miles Gerson, JD, MBA, Partner, Takeda Ventures
Weiyong Sun, MD, PhD, MBA, Senior Director, Searching and Evaluation, Global Business Development, Daiichi Sankyo Group
This panel will cover topics including how investors source and vet novel therapeutic assets, as well as the technology advancing new therapeutics to commercialization and into the hands of patients who need them.